Skip to main content

Tetsuya Mitsudomi, MD, PhD

Tetsuya Mitsudomi, MD, PhD
Videos
09/12/2023
At the 2023 World Conference on Lung Cancer, Tetsuya Mitsudomi, MD, PhD, presented results which demonstrated the addition of perioperative durvalumab to neoadjuvant chemotherapy did not adversely affect surgical outcomes among patients with...
At the 2023 World Conference on Lung Cancer, Tetsuya Mitsudomi, MD, PhD, presented results which demonstrated the addition of perioperative durvalumab to neoadjuvant chemotherapy did not adversely affect surgical outcomes among patients with...
At the 2023 World Conference on...
09/12/2023
Oncology